Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
124 Cards in this Set
- Front
- Back
Entacapone
|
COMT inhibitor; used in treatment of Parkinson's disease
|
|
Octopamine
|
False transmitter formed from tyramine in the presence of MAOIs; accumulates in adrenergic synpatic vesicles and has sympatholytic effectes leading to decreased blood pressure
|
|
Cocaine
|
Blocks monoamine transporter which increases transmitter levels in the synapse; pronounced increase in DA in the brain leading to euphoria, abuse, and dependance; has a local anesthetic effect
|
|
Carbidopa
|
Inhibits DOPA decarboxylase; does not cross the BBB and only works systemically to protect levodopa from metabolism in the PNS
|
|
Levodopa
|
Immediate precursor to dopamine that crosses the BBB to increase dopamine levels in the CNS
|
|
Reserpine
|
Inhibits the transport of monoamine transmitters into the synaptic vesicles, causing the depletion of vesicle monoamine stores lead to sympatholytic effects; it crosses the BBB and leads to CNS depression
|
|
Guanethidine
|
Causes the slow depletion of norepinephrine from nerve terminals; sympatholytic with no CNS activity
|
|
Bretylium
|
Blocks NE release from the nerve ending by inhibiting vesicle fusion; sympatholytic agent that does not cross the BBB; anti-arrhythmic agent
|
|
Acetylcholine
|
Cholinergic neurotransmitter formed from acetylcoA and choline via actyltransferase; very short half-life due to rapid hydrolysis by acetlycholinesterase
|
|
Mecamylamine
|
Non-depolarizing ganglionic antagonist used in the treatment of severe hypertension
|
|
Verenicline
|
Partial nicotinic acetlycholine receptor agonist used as an adjunct in smoking cessation (trade name: Chantix)
|
|
Muscarine
|
Muscarinic receptor agonist isolated from mushrooms; parasympathomimetic
|
|
Pyridostigmine
|
Carbamate cholinesterase inhibitor that does not cross the BBB; used to treat myesthenia gravis and reversal of nondepolarizing NMJ blockers
|
|
VX
|
Nerve gas agent which inhibits acetlycholinesterase
|
|
Atropine
|
Muscarinic receptor antagonist (major belladonna alkaloid)
|
|
Neostigmine
|
Carbamate cholinesterase inhibitor that does not cross the BBB; used to treat myesthenia gravis and reversal of nondepolarizing NMJ blockers
|
|
Carbaryl
|
Carbamate cholinesterase inhibitor used as an insecticide
|
|
Bethanechol
|
Cholinergic agonist selective for muscarinic receptors; not hydrolyzed by cholinesterases
|
|
Sarin
|
nerve gas agent cholinesterase inhibitor
|
|
Hyoscyamine
|
Muscarinic receptor antagonist; relief of GI spasms, irritable bowel syndrome, and spastic colon
|
|
Benztropine
|
Muscarinic receptor antagonist used in the treatment of Parkinson's disease
|
|
Pralidoxime (2-PAM)
|
Cholinesterase reactivator used after organophosphate poisoning (used before "aging" phenomenon occurs)
|
|
Scopolamine
|
Muscarinic antagonist
|
|
Physostigmine
|
Carbamate cholinesterase inhibitor that crosses the BBB
|
|
Nerve gas agents
|
organophosphates that are cholinesterase inhibitors producing depolarization blockade
|
|
Echothiophate
|
Cholinesterase inhibitor used in the treatment of glaucoma
|
|
Nicotine
|
Ganglionic and NMJ agonist that can cause depolarization blockade at high doses; stimulates the release of dopamine in the CNS
|
|
Malathion
|
Cholinesterase inhibitor; prodrug converted to an organophosphate used as a pesticide; inactivated in mammals and birds
|
|
Edrophonium
|
Competitive cholinesterase inhibitor used for the diagnosis and dose adjustment of myesthenia gravis (short acting cholinesterase inhibitor)
|
|
Arecoline
|
Non-specific cholinergic agonist
|
|
Pilocarpine
|
Muscarinic receptor agonist used in the treatment of glaucoma; crosses membranes well
|
|
Parathion
|
Cholinesterase inhibitor; prodrug converted to an organophosphate used as a pesticide; inactivated in mammals and birds
|
|
Donepezil
|
Noncompetitive cholinesterase inhibitor used in the treatment of Alzheimer's
|
|
Tizanidine
|
Selecetive alpha 2 receptor agonist
|
|
Methamphetamine
|
Indirect adrenergic agonist with prominant CNS action
|
|
Amphetamine
|
Indirect adrenergic agonist that stimulates release of catecholamines from the monoamine terminals; major CNS action causing the elevation of central dopamine levels leading to positive reinforcment
|
|
Labetalol
|
Mixed beta and alpha 1 receptor antagonist; antihypertensive agent
|
|
Dopamine
|
Dopaminergic NT producing renal vasodilation, controls motor activity in the caudate-putamen, associated with positive reinforcement in the limbic areas
|
|
Phenoxybenzamine
|
Non-selective alpha receptor antagonist that is long acting and irreversible; used in the treatment of pheochromocytoma
|
|
Propranolol
|
Non-selective beta receptor antagonist
|
|
Norepinephrine
|
Noradrenergic neurotransmitter; good alpha and beta 1 agonist and weak beta 2 agonist
|
|
Methylphenidate
|
Indirect adrenergic agonist that stimulates the release of catecholamine from monoamine terminals (trade name: Ritaline)
|
|
Levalbuterol
|
Selective beta 2 receptor agonist used in the treatment of bronchospasms and COPD
|
|
Ephedrine
|
Partial indirect adrenergic agonist
|
|
Albuterol
|
Selective beta 2 agonist used in the treatment of bronchospasms, asthma, and COPD
|
|
Prazosin
|
Selective alpha 1 antagonist used as a hypertensive agent
|
|
Clonidine
|
Selective alpha 2 agonist; decreases sympathetic outflow to the PNS
|
|
Salmeterol
|
Selective beta 2 receptor agonist used in the treatment of asthma
|
|
Epinephrine
|
Adrenergic agonist; efficacious at both alpha and beta receptors
|
|
Methyldopa
|
Prodrug alpha 2 receptor agonist
|
|
Carvedilol
|
Mixed beta and alpha 1 receptor antagonist
|
|
Timolol
|
Nonselective beta receptor antagonist; used in the treatment of glaucoma and elevated intraocular pressure
|
|
Terazosin
|
Selective alpha 1 receptor antagonist used in the treatment of BPH
|
|
Pseudoephedrine
|
Partial indirect arenergic agonist; decongestant
|
|
Brimonidine
|
Selective alpha 2 agonist
|
|
Ergot alkaloids
|
Partial alpha agonists
|
|
Dobutamine
|
Selective beta 1 agonist
|
|
Isoproterenol
|
Beta receptor agonist used for the management of bronchospasms
|
|
Tyramine
|
Pure indirect adrenergic agonist; inactivated by MAO
|
|
Tamsulosin
|
Selective alpha 1 antagonist used for the treatment of BPH
|
|
Methoxamine
|
Selective alpha 1 agonist used for rapid increase in BP during hypotensive emergencies
|
|
Phenylephrine
|
Selective alpha 1 agonist
|
|
Phentermine
|
Partial indirect adrenergic agonist used as an appetite suppressant
|
|
Atenolol
|
Cardioselective beta 1 antagonist
|
|
Doxazosin
|
Selective alpha 1 antagonist used for the treatment of BPH
|
|
Esmolol
|
Cardioselective, short acting beta 1 receptor antagonist
|
|
Phentolamine
|
Non-selective alpha antagonist
|
|
Baclofen
|
Centrally acting skeletal muscle relaxant; GABA agonist
|
|
Methocarbamol
|
Centrally acting skeletal muscle relaxant; GABA agonist that works at the spinal reflex arc
|
|
Dantrolene
|
Skeletal muscle relaxant that acts within the sarcoplasmic reticulum to inhibit Ca2+ release; used in the treatment of malignant hyperthermia
|
|
Diazepam
|
Anxiolytic and centrally acting muscle relaxant that increases the release of GABA in the CNS
|
|
Botulinum toxin
|
Cholinergic neurtoxin that blocks the release of Ach from the nerve terminal
|
|
Succinylcholine
|
Depolarizing neuromuscular blocker; short acting and NOT hydrolyzed by acetylcholinesterase, but it IS metabolized by butyrylcholinesterase
|
|
Tubocurarine
|
Non-depolarizing neuromuscular blocker; also causes the release of histamine from mast cells
|
|
Atracurium
|
Non-depolarizing neuromuscular blocker
|
|
Pancuronium
|
Long acting non-depolarizing neuromuscular blocker
|
|
Selegiline
|
MAO type B inhibitor used as an adjunct in the treatment of Parkinson's disease
|
|
Ipratropium
|
Muscarinic antagonist used in the treatment of bronchospasms, COPD, and rhinorrhea
|
|
Procaine
|
Local anesthetic of the ester class with a slow onset; hydrolysis by cholinesterase
|
|
Chloroprocaine
|
Local anesthetic of the ester class; rapid onset and metabolized by cholinesterase
|
|
Tetracaine
|
Local anesthetic of the ester class; spinal anesthetic
|
|
Lidocaine
|
Amide local anesthetic with rapid onset and intermediate duration
|
|
Prilocaine
|
Amide local anesthetic with rapid onset; assoicated with methemoglobinemia
|
|
Bupivacaine
|
Amide local anesthetic with high cardiac toxicity; slow onset and long duration
|
|
Dimenhydrinate
|
First generation anti-histamine with anti-cholinergic activity, marked sedation, and anti-motion sickness activity
|
|
Diphenhydramine
|
First generation anti-histamine with anti-cholinergic activty as well as marked sedation and anti-motion sickness activity
|
|
Chlorpheniramine
|
First generation anti-histamine with slight anti-cholinergic activity and slight sedation
|
|
Promethazine
|
First generation anti-histamine with anti-cholinergic activity as well as marked sedation and anti-emetic activity
|
|
Cetirizine
|
Second generation anti-histamine; metabolite of first generation hydroxyzine
|
|
Desloratadine
|
Second generation anti-histamine converted from generic loratadine (claritin)
|
|
Fexofenadine
|
Second generation anti-histamine
|
|
Loratadine
|
Second generation anti-histamine; metabolized to desloratadine (clarinex)
|
|
Olopatadine
|
Anti-histamine given in a topic preparation for allergic conjunctivitis
|
|
Azelastine
|
Anti-histamine given in a topic/drops preparation for allergic conjunctivitis or allergic rhinitis
|
|
Budesonide
|
Nasal steroid for allergic rhinitis
|
|
Fluticasone furoate
|
Nasal steroid for allergic rhinitis
|
|
Mometasone furoate
|
Nasal steroid for allergic rhinitis
|
|
Disulfarim
|
Inhibition of acetaldehyde dehydrogenase; treatment of alcoholism
|
|
Naltrexone
|
Opiate receptor antagonist that reduces the positive reinforcement of alcohol and reduces craving (prevents heavy drinking)
|
|
Acamprosate
|
Restores normal NMDA signal tone and reduces alcohol cravings; decreases alcohol withdraw effects
|
|
Fomepizol
|
Inhibitor of alcohol dehydrogenase used in the treatment of methanol and ethylene glycol poisoning
|
|
Amantadine
|
Increases the synaptic concentration of dopamine; used in the treatment of Parkinson's disease
|
|
Pergolide
|
Dopamine receptor agonist of the ergot alkoloid class
|
|
Bromocriptine
|
Dopamine receptor agonist of the ergot alkoloid class
|
|
Pramipexole
|
Non-ergot dopamine agonist
|
|
Ropinirole
|
Non-ergot dopamine agonist
|
|
Sinemet
|
Combination of carbidopa/levodopa used for treatment of Parkinson's disease
|
|
Tetrabenazine
|
Dopamine depleting agent used in the treatment of Huntington's disease
|
|
Phenelzine
|
MAO-A and B inhibitor used inthe treatment of depression
|
|
Tranylcypromine
|
MAO-A inhibitor used in the treatment of depression
|
|
Amitriptyline
|
Tricyclic antidepressant that increases the concentration of synaptic NE and 5-HT by inhibiting reuptake pumps
|
|
Imipramine
|
Tricyclic antidepressant that increases the concentration of synaptic NE and 5-HT by inhibiting reuptake pumps
|
|
Trazodone
|
Antidepressant that inhibits 5-HT receptors and inhibit 5-HT and NE reuptake; Side effects: priapism and drowsiness
|
|
Nefazodone
|
Antidepressant that inhibits 5-HT receptors and inhibits 5-HT and NE reuptake
|
|
Venlafaxine
|
Antidepressant that inhibits 5-HT and NE pumps as well as some inhibition of DA reuptake
|
|
Bupropion
|
Antidepressant with unknown action; dose dependant increase in seizures
|
|
Amoxapine
|
Metabolite of antipsychotic (loxapine) which also acts as an antidepressant
|
|
Maprotiline
|
Antidepressant that is a potent NE reuptake inhibitor
|
|
Mirtazipine
|
Antidepressant that is a 5-HT and alpha 2 antagonist; it also blocks H1 receptors and produces sedation and weight gain
|
|
Fluoxetine
|
SSRI antidepressant
|
|
Sertraline
|
SSRI antidepressant
|
|
Paroxetine
|
SSRI antidepressant
|
|
Fluvoxamine
|
SSRI antidepressant
|
|
Lithium
|
mood stabilizer used to prevent manic episodes; believed to decrease postsynaptic second messangers IP3 and DAG
|